In a move that has ignited a firestorm of controversy and concern, the US Department of Health and Human Services (HHS) has pulled the plug on $500 million in funding for mRNA vaccine research. The decision, announced by Health Secretary Robert F. Kennedy Jr., a vocal vaccine skeptic, effectively halts 22 projects at the nation’s leading pharmaceutical companies, including Pfizer and Moderna. These projects were aimed at developing rapid-response vaccines for a range of respiratory viruses, including the flu and a potential bird flu pandemic.
Kennedy, in a public statement and social media video, defended the decision by questioning the very foundation of mRNA technology. He claimed that the vaccines “fail to protect effectively” and could even “prolong pandemics” by encouraging viral mutations a theory that has been widely discredited by infectious disease experts. Instead, he said, the funding would be shifted to what he called “safer, broader vaccine platforms” that mimic “natural immunity.”
ALSO READ: US Government cancels $500M for mRNA vaccines in shock move
This policy shift has been met with a chorus of alarm from the medical and scientific communities. Dr. Mike Osterholm, a renowned infectious disease expert, called it “the most dangerous decision in public health in my 50 years in the business.“ Experts universally credit the rapid development of mRNA vaccines with saving millions of lives during the Covid-19 pandemic and warn that without this technology, the US will be dangerously ill-equipped to handle the next major outbreak. Dr. Paul Offit, a vaccine expert and inventor, noted that the speed of mRNA development is its key advantage, a benefit the US is now abandoning.
This isn’t the first time Kennedy has moved to reshape the nation’s health policy. Since taking office, he has systematically dismantled long-standing vaccine protocols. In recent months, he has fired the entire committee that issues official government vaccine recommendations, replaced them with skeptics, and removed the Covid-19 vaccine from the recommended schedule for healthy children and pregnant women. These actions have led to a lawsuit from a coalition of medical organizations.
The cancellation of the mRNA funding, which was overseen by the Biomedical Advanced Research and Development Authority (BARDA), is a significant blow to biosecurity and pandemic preparedness. While HHS stated that other mRNA research at the National Institutes of Health (NIH) would not be impacted, former officials argue that the signal sent by this move is clear: the U.S. is stepping back from its leadership role in a critical area of medical innovation, potentially leaving the country at the mercy of other nations in a future health crisis.